References
- Algandaby MM, El-Halawany AM, Abdallah HM, Alahdal AM, Nagy AA, Ashour OM, Abdel-Naim AB. 2016. Gingerol protects against experimental liver fibrosis in rats via suppression of pro-inflammatory and profibrogenic mediators. Naunyn Schmiedebergs Arch Pharmacol. 389(4):419–428.
- Campana L, Iredale JP. 2017. Regression of liver fibrosis. Semin Liver Dis. 37(1):1–10.
- Jamjute P, Ahmad A, Ghosh T, Banfield P. 2009. Liver function test and pregnancy. J Matern Fetal Neonatal Med. 22(3):274–283.
- Liu YM. 1999. Pharmacography of Uighur, Part One. Vol.119. Urumuqi: Xinjiang Science & Technology & Hygiene Publishing House.
- Luedde T, Schwabe RF. 2011. NF-κB in the liver-linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 8(2):108–118.
- Maierdan T, Liu T, Li CY, Chen Y, Xu F, Zhao J. 2018. Preventive effect of isostrictiniin from Nymphaea candida on acute liver induced by CCl4 in mice and its antioxidant activities in vitro. J Xinjiang Med Univi. 41(3):321–325.
- Marques TG, Chaib E, da Fonseca JH, Lourenço ACR, Silva FD, Ribeiro MAF, Galvão FHF, D'Albuquerque LAC. 2012. Review of experimental models for inducing hepatic cirrhosis by bile duct ligation and carbon tetrachloride injection. Acta Cir Bras. 27(8):589–594.
- Maurizio P, Massimo P. 2019. Liver fbrosis: Pathophysiology, pathogenetic targets and clinical issues. Mol Asp Med. 65:37–55.
- Seki E, Schwabe RF. 2015. Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology. 61(3):1066–1079.
- Wang R, Song F, Li S, Wu B, Gu Y, Yuan Y. 2019. Salvianolic acid A attenuates CCl4-induced liver fibrosis by regulating the PI3K/AKT/mTOR, Bcl-2/Bax and caspase-3/cleaved caspase-3 signaling pathways. Drug Des Devel Ther. 13:1889–1900.
- Weber L, Boll M, Stampfl A. 2003. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol. 33(2):105–136.
- Yanguas SC, Cogliati B, Willebrords J, Maes M, Colle I, van den Bossche B, de Oliveira CPMS, Andraus W, Alves VAF, Leclercq I, et al. 2016. Experimental models of liver fibrosis. Arch Toxicol. 90(5):1025–1048.
- Yu B, Qin SY, Hu BL, Qin QY, Jiang HX, Luo W. 2019. Resveratrol improves CCL4-induced liver fibrosis in mouse by upregulating endogenous IL-10 to reprogramme macrophages phenotype from M(LPS) to M(IL-4). Biomed Pharmacother. 117:109110.
- Zhan Y, Wang JH, Tian X, Feng SX, Xue L, Tian LP. 2016. Protective effects of seed melon extract on CCl4-induced hepatic fibrosis in mice. J Ethnopharmacol. 193:531–537.
- Zhang S, You SP, Liu T, Zhao J, TF J, Xu F. 2016. Preventive effects of total flavonoids from Nymphaea candida on CCl4 induced acute liver injury in mice. Nat Prod Res Dev. 28:2017–2020.
- Zhao J, Liu T, Ma L, Yan M, Gu ZY, Huang Y, Xu F, Zhao Y. 2011. Antioxidant and preventive effects of extract from nymphaea Candida flower on in vitro immunological liver injury of rat primary hepatocyte cultures. Evid Based Complement Alternat Med. 2011:1–8.
- Zhao J, Maierdan T, Ji F, Liu T, Xu F. 2021. Hepatoprotective activity of isostrictiniin from Nymphaea candida on Con A-induced acute liver injury in mice. Nat Prod Res. 35:1662-1666.
- Zheng H, Wang X, Zhang Y, Chen L, Hua L, Xu W. 2019. Pien-Tze-Huang ameliorates hepatic fibrosis via suppressing NF-κB pathway and promoting HSC apoptosis. J Ethnopharmacol. 244:111856.